These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 11905138)
1. More hot topics in HIV/AIDS. Laurence J AIDS Read; 2002 Feb; 12(2):48-9. PubMed ID: 11905138 [No Abstract] [Full Text] [Related]
2. Putting resistance to the test. Daar ES Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369 [No Abstract] [Full Text] [Related]
3. Clinicians debate antiretroviral tactics and toxicities, resistance testing, and hepatitis virus coinfection. IAPAC sessions 2002 - May 16-17, 2002. Mascolini M IAPAC Mon; 2002 Jul; 8(7):190-201. PubMed ID: 12154789 [No Abstract] [Full Text] [Related]
4. Anti-HIV agents. A few reasons for starting therapy at CD4+ counts above 350 cells. TreatmentUpdate; 2009 Jan; 21(1):4-5. PubMed ID: 19248283 [No Abstract] [Full Text] [Related]
5. German-Austrian recommendations for HIV-therapy in pregnancy--common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH). Buchholz B; Marcus U; Beichert M; Grubert T; Gingelmaier A; Kaestner R; Grosch-Woerner I; Brockmeyer NH; ; ; ; ; ; ; ; ; Eur J Med Res; 2002 Oct; 7(10):417-33. PubMed ID: 12435621 [TBL] [Abstract][Full Text] [Related]
6. Taking the pulse of HIV medicine in Europe. IAPAC sessions 2004--Europe. September 23-24, 2004, London. Meldrum J IAPAC Mon; 2004 Nov; 10(11):416-20, 425-30. PubMed ID: 15744892 [No Abstract] [Full Text] [Related]
7. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion. Corales RB; Djeloski DS; Mancenido MD; Valenti WM AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330 [No Abstract] [Full Text] [Related]
8. [Co-infection with HIV and viral hepatitis C]. Pialoux G Med Mal Infect; 2006 Jul; 36 Suppl 2():S218-23. PubMed ID: 17076000 [No Abstract] [Full Text] [Related]
9. HIV drug resistance testing: data be damned. Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172 [No Abstract] [Full Text] [Related]
10. Research. Significant strides made in HIV/AIDS services but many obstacles remain. AIDS Policy Law; 2010 Nov; 25(12):1. PubMed ID: 21174636 [No Abstract] [Full Text] [Related]
11. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients. Núñez M; Soriano V J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208 [No Abstract] [Full Text] [Related]
14. Questions about HIV and pregnancy. Ball SC AIDS Read; 2002 Jul; 12(7):301-4. PubMed ID: 12161851 [No Abstract] [Full Text] [Related]
15. Bush proposes additional $500M in HIV/AIDS funding. AIDS Policy Law; 2002 Jul; 17(12):8. PubMed ID: 12134800 [No Abstract] [Full Text] [Related]
16. Side effects. Effect of combination therapy on pregnancy--results from Europe. TreatmentUpdate; 2001; 12(9):5. PubMed ID: 12132447 [No Abstract] [Full Text] [Related]
17. FDA notifications. Revised guidelines for pregnant women. AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483 [No Abstract] [Full Text] [Related]
18. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151 [No Abstract] [Full Text] [Related]